Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05798793
What this trial is testing

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma
Hospital of Stomatology, Wuhan University 309
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07137858
What this trial is testing

Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Neoadjuvant Chemoimmunotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814158
What this trial is testing

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Who this might be right for
Esophageal Squamour Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 57
Testing effectiveness (Phase 2)Study completedNCT00069953
What this trial is testing

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Testing effectiveness (Phase 2)Study completedNCT03342911
What this trial is testing

Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

Who this might be right for
Name Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma+19 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Testing effectiveness (Phase 2)Looking for participantsNCT07586124
What this trial is testing

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lepu Biopharma Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01884259
What this trial is testing

Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

Who this might be right for
Squamous Cell Carcinoma of the Hypopharynx Stage IIISquamous Cell Carcinoma of the Hypopharynx Stage IVSquamous Cell Carcinoma of the Larynx Stage III+5 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677475
What this trial is testing

MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Dongguan People's Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT06494943
What this trial is testing

Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Fudan University 27
Early research (Phase 1)Looking for participantsNCT07455032
What this trial is testing

Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Fox Chase Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Large-scale testing (Phase 3)Looking for participantsNCT07524452
What this trial is testing

Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ming-Yuan Chen 430
Testing effectiveness (Phase 2)UnknownNCT05650216
What this trial is testing

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 50
Large-scale testing (Phase 3)Looking for participantsNCT04138212
What this trial is testing

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 456
Early research (Phase 1)Study completedNCT04393506
What this trial is testing

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Who this might be right for
Oral CancerVEGFR2 InhibitorProgrammed Cell Death 1 Inhibitor+1 more
Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)UnknownNCT04624308
What this trial is testing

Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC

Who this might be right for
Hypopharyngeal Neoplasm Malignant Primary
Sun Yan 81
Large-scale testing (Phase 3)Not Yet RecruitingNCT06861777
What this trial is testing

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
YIN LI 474
Testing effectiveness (Phase 2)Study completedNCT00445861
What this trial is testing

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 27
Not applicableNot Yet RecruitingNCT07457099
What this trial is testing

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Oral Squamous Cell CarcinomaLocally Advanced Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital 85
Next Page